When the lobbyist for the Vermont Association of Hospitals and Health Systems was asked by a legislator why Vermont has the highest markup on outpatient drugs in the nation she said she didn’t know. She said she was not even sure Vermont’s hospitals were aware of their disproportionate billing practices.
Given the extraordinary scrutiny of Vermont’s health care costs, and the fact that Vermont’s hospitals have to defend their budgets before the Green Mountain Care Board, it seems a stretch to suggest hospitals don’t know why the prices they charge are so high.
Of course, they know. To say otherwise is like suggesting a local manufacturer doesn’t know how many employees they have on staff. Or what they pay for utilities. Or healthcare for their employees. Pharmaceuticals are a significant part of a hospital’s costs/revenue. They know to the penny.
Explaining why they charge what they charge is another matter. No matter the answer it sounds like, in the words of one legislator, price gouging.
That was the stage set last Friday in the Statehouse as legislators debated the wisdom of a prescription pricing bill. Legislators were reviewing a report by RAND, a national policy think tank, that showed Vermont hospitals charge roughly five times the national average for outpatient pharmaceuticals. The largest offender - because it’s the largest hospital - is the University of Vermont Medical Center [UVMMC].
Several examples were given:
• UVMMC charges 2,312 percent above the average sales price for Inflectra, an anti-inflammatory drug.
These examples were compiled by BlueCross Blue Shield Vermont [BCBSVT] and provided as part of the testimony before the Legislature. The exorbitant costs are part of the reason the insurer is on the brink of insolvency. It was noted in the company’s testimony that if the Legislature passed the bill under consideration - which would ultimately limit pricing to 120 percent of the average sales price - BCBSVT could cut its proposed double-digit price increase by four percentage points for individual and small group insurance plans and by three percent for school health insurance plans.
That’s real money.
The frustration in all this is universal. In a Vermont Digger story, Devon Green, the lobbyist for the state’s hospitals was quoted as saying: “I do not think that it is right. And I think it is an unfortunate byproduct of a very flawed way of paying for health care.”
By flawed what she means is that when hospitals feel pressured by low Medicare or Medicaid reimbursement levels, or the GMCB’s limitation of what they can generate in revenue, hospitals search for another avenue. It’s like squeezing a balloon. Squeeze the middle and it expands at the edges.
One primary reason hospitals feel the need to charge more for pharmaceuticals is that Vermont is at the bottom of the heap when it comes to reimbursement levels set by Medicaid and Medicare. James Trimarchi, who is the planning director of Southwestern Vermont Medical Center told legislators that Vermont’s hospitals are the least paid “of any hospitals in any state in the union.”
Why? “We don’t know,” he said.
Really? Vermont’s hospitals don’t know why they are being paid for what they do? The answer to that question is unknown? UVMMC, far and away Vermont’s largest hospital, with an administrative staff to match, doesn’t know how or why Medicare and Medicaid rates are what they are?
That can’t be right. If that were true, how would the hospital know to what level it should raise its price for outpatient pharmaceuticals to make up the difference between what Medicare and Medicaid pay, versus the cost to deliver that care?
The longer the debate goes on the more apparent it is that there is an assumed advantage in obfuscation. If the public, our legislators, and the state’s regulator don’t know the numbers or are not told how the numbers work, or what they represent, then developing a sustainable healthcare system is borderline impossible.
Perhaps that’s the reason the Oliver Wyman report, commissioned by the GMCB, last fall concluded that the state’s healthcare system was destined for a bleak future if it didn’t change.
That change can only begin by trusting the numbers and the processes used to gain that trust.
Currently, that trust does not exist.
By Emerson Lynn
Comments
No comments on this item Please log in to comment by clicking here